Diabetic Medication Lawyers
What is a Diabetic Medical Lawsuit? What Can A Diabetic Medication Lawyer Do For You?
Some diabetic drugs designed to treat Type 2 diabetes have been linked to pancreatic and or thyroid cancer. Diabetic medications that may be linked to increased cancer risk include: Byetta, Januvia and Victoza.
Lawsuits have been filed against the manufacturers of these drugs alleging that patients did not receive adequate warning about the risks of taking these medications.
The diabetic medical lawsuits are being filed under the claims that drug companies:
- Failed to investigate the accuracy of diabetic medication labels, even after they knew about potential risks
- Knew that using certain diabetic medications for long periods of time increased the risk of cancer
- Failed to conduct and report post-market safety studies on these medications
Diabetic Medications With Serious Side Effects
The FDA released warnings for several Type 2 diabetes drugs including:
Actos: The use of Actos for more than a year may increase the risk of developing bladder cancer and heart attacks. In 2007, the FDA released warnings and required Actos manufacturer, Takeda Pharmaceutical Co., to include warning that patients should not use the drug. Class action lawsuits have been ongoing.
Byetta, Januvia: These diabetic medications are associated with a six-times-greater risk of pancreatitis and pancreatic cancer, according to researchers at UCLA. In 2011, Byetta, manufactured by Amylin Pharmaceuticals, was reported to elevate the risk of pancreatic cancer. It’s estimated that 10 million prescriptions have been filled for Byetta. An estimated 18 million prescriptions have been filled for Januvia, which is manufactured by Merck & Co.
Victoza: FDA’s medication guide says that this drug is linked to the development of thyroid tumors, which may be cancerous. Like the other incretin mimetic drugs, there is concern that Victoza may be linked to pancreatitis.
Avandia: According to a report published in the New England Journal of Medicine Avandia causes a 43 percent higher risk of heart attack. It is still being prescribed despite this research, and it may be responsible for 100,000 deaths in the United States alone. GlaxoSmithKline, the manufacturer of Avandia, agreed to pay the government $3 billion to settle civil and criminal cases after they admitted that Avandia side effects include an increased risk of heart attack.
Although these drugs are facing diabetic medical lawsuits, many diabetes drugs, including Januvia, Byetta and Victoza, have yet to be recalled. Contrary to popular belief most recalls are issued by drug manufacturers and not the FDA.